The threat of an integrated pharmacy could spur consolidation in a disrupted health care space.
Learn more about the four largest individual shareholders in CVS.
Without a major acquisition, the pharmacy industry is too complex for Amazon, says WBA's CEO.
CVS stock is bouncing after a decline triggered by Aetna merger talks and Amazon's ambitions, but it could sell off at new resistance.
Correspondence between the e-commerce giant and regulators suggests that Amazon will concentrate on selling medical devices and supplies, for now at least.
Analysts take to the sidelines on CVS stock until clarity emerges on issues like Amazon's Rx entry.
As a consolidator, Amazon could reduce healthcare costs on Main Street and solve some problems related to Obamacare.
As headwinds in retail pharmacy intensify, Walgreens investors should expect no relief.
CVS made a $66B offer for insurer Aetna, prompted in part by Amazon's potential next move.
Pharmacy shares tumbled after a report indicated that Amazon might now be able to start selling prescription drugs online.